Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease
- PMID: 16240369
- DOI: 10.1002/ana.20682
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease
Abstract
We investigated whether nonsteroidal antiinflammatory drug use was associated with a lower risk for Parkinson's disease (PD) in a large cohort of US men and women. PD risk was lower among ibuprofen users than nonusers. Compared with nonusers, the relative risks were 0.73 for users of fewer than 2 tablets/week, 0.72 for 2 to 6.9 tablets/week, and 0.62 for 1 or more tablets/day (p trend = 0.03). No association was found between the use of aspirin, other nonsteroidal antiinflammatory drugs, or acetaminophen and PD risk. The results suggest that ibuprofen use may delay or prevent the onset of PD.
Comment in
-
Ibuprofen and the mouse model of Parkinson's disease.Ann Neurol. 2006 Jun;59(6):988-9. doi: 10.1002/ana.20860. Ann Neurol. 2006. PMID: 16718707 No abstract available.
Similar articles
-
Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease.Mov Disord. 2006 Jul;21(7):964-9. doi: 10.1002/mds.20856. Mov Disord. 2006. PMID: 16550541
-
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.Arch Neurol. 2003 Aug;60(8):1059-64. doi: 10.1001/archneur.60.8.1059. Arch Neurol. 2003. PMID: 12925360
-
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.Neuroepidemiology. 2007;28(4):193-6. doi: 10.1159/000108110. Epub 2007 Sep 11. Neuroepidemiology. 2007. PMID: 17851257
-
NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies.Drugs Aging. 2009;26(9):769-79. doi: 10.2165/11316780-000000000-00000. Drugs Aging. 2009. PMID: 19728750 Review.
-
Use of non-aspirin nonsteroidal antiinflammatory drugs and the risk of cardiovascular events.Ann Pharmacother. 2006 Oct;40(10):1785-96. doi: 10.1345/aph.1H048. Epub 2006 Sep 19. Ann Pharmacother. 2006. PMID: 16985093 Review.
Cited by
-
The relation between Parkinson's disease and non-steroidal anti-inflammatories; a systematic review and meta-analysis.Front Pharmacol. 2024 Jul 31;15:1434512. doi: 10.3389/fphar.2024.1434512. eCollection 2024. Front Pharmacol. 2024. PMID: 39156113 Free PMC article.
-
The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson's disease.Sci Rep. 2024 Jun 25;14(1):14670. doi: 10.1038/s41598-024-65640-x. Sci Rep. 2024. PMID: 38918550 Free PMC article.
-
The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.Int J Mol Sci. 2024 Apr 15;25(8):4358. doi: 10.3390/ijms25084358. Int J Mol Sci. 2024. PMID: 38673943 Free PMC article. Review.
-
Investigating the Effect of an Anti-Inflammatory Drug in Determining NURR1 Expression and Thus Exploring the Progression of Parkinson's Disease.Physiol Res. 2024 Mar 11;73(1):139-155. doi: 10.33549/physiolres.935168. Physiol Res. 2024. PMID: 38466012 Free PMC article.
-
What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson's Disease?Int J Mol Sci. 2024 Jan 29;25(3):1641. doi: 10.3390/ijms25031641. Int J Mol Sci. 2024. PMID: 38338925 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
